Found: 16
Select item for more details and to access through your institution.
Sertad1 antagonizes iASPP function by hindering its entrance into nuclei to interact with P53 in leukemic cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Experimental Study of CO<sub>2</sub>-Water-Mineral Interactions and Their Influence on the Permeability of Coking Coal and Implications for CO<sub>2</sub>-ECBM.
- Published in:
- Minerals (2075-163X), 2018, v. 8, n. 3, p. 117, doi. 10.3390/min8030117
- By:
- Publication type:
- Article
Longitudinal genetically detectable minimal residual disease by fluorescence in situ hybridization confers a poor prognosis in myeloma.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231221340
- By:
- Publication type:
- Article
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM).
- Published in:
- Annals of Hematology, 2024, v. 103, n. 4, p. 1305, doi. 10.1007/s00277-023-05573-z
- By:
- Publication type:
- Article
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 6, p. 1473, doi. 10.3390/cancers12061473
- By:
- Publication type:
- Article
Variable metric proximal stochastic variance reduced gradient methods for nonconvex nonsmooth optimization.
- Published in:
- Journal of Industrial & Management Optimization, 2022, v. 18, n. 4, p. 2611, doi. 10.3934/jimo.2021084
- By:
- Publication type:
- Article
OAB-021: BCMA-specific ADC MEDI2228 and Daratumumab induce synergistic myeloma cytotoxicity via enhanced IFN-driven innate immune responses and expression of CD38 and NKG2D ligands.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S13, doi. 10.1016/S2152-2650(21)02095-4
- By:
- Publication type:
- Article
Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
- Published in:
- 2020
- By:
- Publication type:
- journal article
MEDI2228, a novel BCMA pyrrolobenzodiazepine antibody drug conjugate, overcomes drug resistance and synergizes with bortezomib and DNA damage response inhibitors in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e154, doi. 10.1016/j.clml.2019.09.257
- By:
- Publication type:
- Article
YWHAE/14-3-3ε expression impacts the proteasome load contributing to proteasome inhibitor sensitivity in multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e111, doi. 10.1016/j.clml.2019.09.184
- By:
- Publication type:
- Article
AMG 701, a half-life extended anti-BCMA BiTE®, potently induces T cell-redirected lysis of human multiple myeloma cells and can be combined with IMiDs to overcome the immunosuppressive bone marrow microenvironment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e54, doi. 10.1016/j.clml.2019.09.082
- By:
- Publication type:
- Article
APOBEC3B is induced by activation of DNA damage pathway and regulates the survival and treatment response in human multiple myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e51, doi. 10.1016/j.clml.2019.09.078
- By:
- Publication type:
- Article
PHF19 Promotes Drug Resistance via Increased EZH2 Phosphorylation in Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e21, doi. 10.1016/j.clml.2019.09.031
- By:
- Publication type:
- Article
γ-secretase inhibitors augment efficacy of BCMA-targeting bispecific antibodies against multiple myeloma cells without impairing T-cell activation and differentiation.
- Published in:
- Blood Cancer Journal, 2022, v. 12, n. 8, p. 1, doi. 10.1038/s41408-022-00716-3
- By:
- Publication type:
- Article
VIS832, a novel CD138-targeting monoclonal antibody, potently induces killing of human multiple myeloma and further synergizes with IMiDs or bortezomib in vitro and in vivo.
- Published in:
- Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00378-z
- By:
- Publication type:
- Article
Monoclonal Antibody: A New Treatment Strategy against Multiple Myeloma.
- Published in:
- Antibodies (2073-4468), 2017, v. 6, n. 4, p. 18, doi. 10.3390/antib6040018
- By:
- Publication type:
- Article